ClinicalTrials.Veeva

Menu

Observational Study to Assess Optimal ECPR Settings After Resuscitation (MOFE)

Erasmus University logo

Erasmus University

Status

Completed

Conditions

Extracorporeal Cardiopulmonary Resuscitation
Cardiac Arrest

Treatments

Other: Settings of the extracorporeal membrane oxygenation (ECMO)

Study type

Observational

Funder types

Other

Identifiers

NCT03592810
NL60632.078.17

Details and patient eligibility

About

Rationale: Veno-arterial extracorporeal membrane oxygenation (vaECMO) during cardiopulmonary resuscitation (ECPR) might improve outcome after cardiac arrest. However, it is well established that reperfusion injury of the brain can cause microvascular and endothelial dysfunction, leading to cellular necrosis and apoptosis. While performing ECPR, following the European resuscitation guidelines, it is yet unknown how to set the ECMO settings in order to minimize ischemia-reperfusion injury of the brain.

Objective: In this study, we want to elaborate on the optimal ECMO settings in the first three hours after initiation of ECPR.

Study design: Prospective, multi-centre, observational study Study population: All patients receiving ECPR in the age between 18 and 70 years, with low flow duration<60min and receiving cerebral oximetry monitoring Intervention: application of an adhesive regional oximetry sensor on the patient's forehead and withdrawal of 12 ml extra blood in all patients.

Main study parameters/endpoints: Cerebral Performance Category at 6 months. Neuron-specific enolase (NSE) will be determined from routine blood drawings.

Enrollment

26 patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Witnessed cardiac arrest or signs of life during CPR (such as gasping or movement)
  • Age>18 and < 70 years
  • Duration of low-flow < 60 min before decision to proceed with ECPR
  • High quality CPR (defined as end-tidal carbon dioxide (CO2et) >10 mmHg) provided for a minimum of 15 minutes without return of spontaneous circulation (ROSC)
  • Presumed cardiac cause of cardiac arrest (such as Chest pain before collapse, ventricular tachycardia/ventricular fibrillation (VT/VF) as initial rhythm or ST-elevation on ECG)
  • Cerebral oxymetry monitoring initiated during CPR preceding ECPR

Exclusion criteria

  • Patients with a GCS<15 before CPR.
  • Known pre-arrest cerebral performance category CPC ≥ 3
  • Presumed noncardiac cause
  • Unwitnessed collapse
  • Suspected or confirmed pregnancy
  • ROSC within 5 minutes of Advanced cardiopulmonary life support (ACLS) performed by emergency medical service (EMS) team
  • Conscious patient
  • Known bleeding diathesis or suspected or confirmed acute or recent intracranial bleeding
  • Suspected or confirmed acute stroke
  • Known severe chronic organ dysfunction or other limitations to therapy
  • "Do not resuscitate" order or other circumstances that make 180 day survival unlikely

Trial design

26 participants in 1 patient group

ECPR
Description:
All patients who received ECMO placement during cardiopulmonary resuscitation (ECPR)
Treatment:
Other: Settings of the extracorporeal membrane oxygenation (ECMO)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems